Literature DB >> 15908735

Does vestibular damage cause cognitive dysfunction in humans?

Paul F Smith1, Yiwen Zheng, Arata Horii, Cynthia L Darlington.   

Abstract

For more than a decade, evidence from animal studies has suggested that damage to the vestibular system leads to deficits in spatial navigation which are indicative of impaired spatial learning and memory. More recently, direct evidence has emerged to demonstrate that humans with vestibular disorders exhibit a range of cognitive deficits that are not just spatial in nature, but also include non-spatial functions such as object recognition memory. Vestibular dysfunction has been shown to adversely affect attentional processes and increased attentional demands can worsen the postural sway associated with vestibular disorders. Recent MRI studies also show that humans with bilateral vestibular damage undergo atrophy of the hippocampus which correlates with their degree of impairment on spatial memory tasks. These results are consistent with those from animal studies and, together, suggest that humans with vestibular disorders are likely to experience cognitive dysfunction which is not necessarily related to any particular episode of vertigo or dizziness, and therefore may occur even in patients who are otherwise well compensated. These findings may be related to the observation that patients with vestibular deficits experience a high incidence of depression and anxiety disorders.

Entities:  

Mesh:

Year:  2005        PMID: 15908735

Source DB:  PubMed          Journal:  J Vestib Res        ISSN: 0957-4271            Impact factor:   2.435


  31 in total

1.  Perceptual and motor inhibition in individuals with vestibular disorders.

Authors:  Maha T Mohammad; Susan L Whitney; Patrick J Sparto; J Richard Jennings; Joseph M Furman
Journal:  J Neurol Phys Ther       Date:  2010-06       Impact factor: 3.649

2.  Linear path integration deficits in patients with abnormal vestibular afference.

Authors:  Joeanna C Arthur; Kathleen B Kortte; Mark Shelhamer; Michael C Schubert
Journal:  Seeing Perceiving       Date:  2012

3.  Anatomical and Physiological Considerations in Vestibular Dysfunction and Compensation.

Authors:  Sherri M Jones; Timothy A Jones; Kristal N Mills; G Christopher Gaines
Journal:  Semin Hear       Date:  2009

4.  Electrical Stimulation Normalizes c-Fos Expression in the Deep Cerebellar Nuclei of Depressive-like Rats: Implication of Antidepressant Activity.

Authors:  Gemma Huguet; Elisabet Kadar; Yasin Temel; Lee Wei Lim
Journal:  Cerebellum       Date:  2017-04       Impact factor: 3.847

5.  Mental transformation abilities in patients with unilateral and bilateral vestibular loss.

Authors:  Luzia Grabherr; Cyril Cuffel; Jean-Philippe Guyot; Fred W Mast
Journal:  Exp Brain Res       Date:  2011-02-02       Impact factor: 1.972

Review 6.  Vestibular dysfunction: prevalence, impact and need for targeted treatment.

Authors:  Yuri Agrawal; Bryan K Ward; Lloyd B Minor
Journal:  J Vestib Res       Date:  2013       Impact factor: 2.435

7.  Acute peripheral vestibular deficit increases redundancy in random number generation.

Authors:  Ivan Moser; Dominique Vibert; Marco D Caversaccio; Fred W Mast
Journal:  Exp Brain Res       Date:  2016-11-15       Impact factor: 1.972

8.  Influence of galvanic vestibular stimulation on egocentric and object-based mental transformations.

Authors:  Bigna Lenggenhager; Christophe Lopez; Olaf Blanke
Journal:  Exp Brain Res       Date:  2007-08-24       Impact factor: 1.972

Review 9.  Electrical stimulation of cranial nerves in cognition and disease.

Authors:  Devin Adair; Dennis Truong; Zeinab Esmaeilpour; Nigel Gebodh; Helen Borges; Libby Ho; J Douglas Bremner; Bashar W Badran; Vitaly Napadow; Vincent P Clark; Marom Bikson
Journal:  Brain Stimul       Date:  2020-02-23       Impact factor: 8.955

10.  Modulation of memory by vestibular lesions and galvanic vestibular stimulation.

Authors:  Paul F Smith; Lisa H Geddes; Jean-Ha Baek; Cynthia L Darlington; Yiwen Zheng
Journal:  Front Neurol       Date:  2010-11-17       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.